OpenAI faces some user criticism over its new deal with the Department of Defense.
Trending
- Pfizer Lyme disease vaccine fails trial, company to seek FDA approval
- Paraguay signals neutral stance with pause in easing cycle
- Gold enters bear market as Bitcoin ETFs attract record inflows
- Amazon’s Prime Day Shift: Why Moving It to June Matters
- CLARITY Act Update: Crypto and Bank Reps Head to Capitol Hill to Review Stablecoin Deal as Details Remain Under Wraps
- US, TotalEnergies to shift nearly $1 billion from wind to oil and gas
- Rivian’s Making a Big Pivot, and the Results Could Be Huge
- Fed's Miran Says Policy Can't Be Made on Short-Term Headlines
Tuesday, March 24
